Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Zannan and AB Pharma develop novel highly potent HCV NS3/NS4A inhibitor

April 13, 2012

Merck & Co. discovers new potential schizophrenia therapies

April 12, 2012

Amgen reports discovery of novel class of prostanoid EP2 receptor antagonists

April 12, 2012

First-in-human data presented on hypomethylating anticancer agent

April 12, 2012

Tetraphase Pharmaceuticals describes antibacterial activity of novel pentacycline

April 12, 2012

Scientists in U.S. develop new mouse model to study radiation effects

April 12, 2012

New orally bioavailable TTK inhibitor described

April 12, 2012

Novel ApoA-I-mimetic peptide shows promise as atherosclerosis drug

April 11, 2012

Mutant caveolin-1-derived peptide reduces atherosclerotic lesions

April 11, 2012

Takeda reports on efforts to develop new HER2/EGFR kinase inhibitors

April 11, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...